# Pharmacokinetics & Dosing Mebendazole dosing in oncology is very different from routine anti-parasitic use, which is why the pharmacokinetic and clinical-trial context matters. ### General dosing themes The most relevant themes from the early oncology literature are: * tolerated higher-dose use in cancer settings * biomarker effects at standard safe oral doses in some studies * the need to think in oncology-specific rather than household anti-parasitic terms ### Clinical dosing signals * A Phase 2a study found mebendazole was safe and well tolerated up to **4 g/day** in cancer patients * In metastatic colorectal cancer, **500 mg twice daily** produced meaningful VEGF reduction and signal of response improvement after 12 weeks ### Practical interpretation The oncology discussion is not just `What is the standard anti-parasitic dose?` It is `What dose is being explored for anti-cancer purposes, in what setting, and under what monitoring?` ### Key References A phase 2a clinical study on the safety and efficacy of mebendazole in cancer\ Mebendazole in metastatic colorectal cancer: anti-VEGF effects at tolerated dose\ {% hint style="warning" %} This information is for education only. It is not medical advice, diagnosis, or treatment. Please speak with a qualified clinician before making changes to care, medication, or supplement use. {% endhint %} {% hint style="info" %} © 2026 Abbey Mitchell. All rights reserved. Please share by URL rather than copying page text. {% endhint %} --- # Agent Instructions: Querying This Documentation If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question. Perform an HTTP GET request on the current page URL with the `ask` query parameter: ``` GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/off-label-drugs-for-cancer/mebendazole-in-oncology/pharmacokinetics-and-dosing.md?ask= ``` The question should be specific, self-contained, and written in natural language. The response will contain a direct answer to the question and relevant excerpts and sources from the documentation. Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.